Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Cancer
-
-
-
-
-
-
-
anti-Fibronectin (EDA), mAb (blocking) (IST-9) (preservative free)
AG-20B-6001YPF AG-20B-6001YPF-C100 100 µg CHF 290.00AG-20B-6001YPF-C500 500 µg CHF 730.00Replaces AG-20B-6001PF
-
![Immunofluorescence using anti-PARP-10 [ARTD10] (human), mAb (5H11). Method: T47D mammary carcinoma cells were stained by indirect immunofluorescence and analysed. Prior to fixation and staining, the cells were treated with or without 50nm leptomyci](https://adipogen.com/pub/media/catalog/product/cache/small_image/240x240/beff4985b56e3afdbeabfc89641a4582/a/g/ag-20t-0004-if.png)
-
anti-Periostin, mAb (blocking) (OC-20) (preservative free)
AG-20B-6000YPF AG-20B-6000YPF-C100 100 µg CHF 470.00AG-20B-6000YPF-C500 500 µg CHF 1'900.00Replaces AG-20B-6000PF
-
anti-Poly(ADP-ribose) [PAR], mAb (10H)
AG-20T-0001 AG-20T-0001-C050 50 µg CHF 190.00AG-20T-0001-C100 100 µg CHF 290.00AG-20T-0001-M001 1 mg CHF 860.00![anti-Poly(ADP-ribose) [PAR], mAb (10H)](https://adipogen.com/pub/media/catalog/product/cache/small_image/240x240/beff4985b56e3afdbeabfc89641a4582/a/g/ag-20t-0001-10h-immunohistochemistry.jpg)